In response to media questions about "inconsistent data before and after the IPO filing," the Shenzhen Stock Exchange issued an inquiry letter to the Huada Gene yesterday. Subsequently, Huada Gene replied that the data inconsistency was caused by “different statistical caliberâ€. In addition, the three lawsuits referred to by the media, Huada Gene said that it only participates in litigation as a third party and is not a statutory disclosure. As of yesterday, Huada's stock price fell twice in the past three trading days, with a cumulative decline of nearly 26%. The enquiry letter pointed out that there were media reports that Huada Gene's IPO filings on December 11, 2015 (hereinafter referred to as "old version of the draft") and March 14, 2017 (hereinafter referred to as "new version of the draft" In the report, the production and sales data of reproductive health services in 2014 were inconsistent (the data before and after were 515,600 and 425,100, respectively, with a change of about 17.54%). In addition, the company's shareholders also involved litigation cases related to the construction of the Huada Gene Center and the Shenzhen Construction Land Planning Permit under BH-2011-0032. Huada Gene replied that the data inconsistency was caused by "different statistical calibers." Among them, the old version of the draft report reflects the capacity and capacity utilization rate, and taking into account the characteristics of the “emerging industry†of genetic testing, Huada Gene selected the number of actual test samples (“number of machinesâ€) in the production and delivery center as the statistical caliber, and according to The industry's "sales by sales" feature launched the year's sales. If the new version of the draft is more in line with the actual concept of external production and sales, the disclosure will be adjusted to the number of samples of the final delivery test report ("report number"). Huada Gene said that this will not affect the financial report during the reporting period, nor will it affect investors' investment judgment. In addition, Huada Gene said that the lawsuits were three administrative actions triggered by the opposition of some residents to the Huada Holdings-related production projects. Including "Zeng Wenying and other five cases that originally told the Shenzhen Habitat Environment Committee" (hereinafter referred to as "Zeng Wenying Case"), "Zheng Qiang v. Shenzhen Planning and Land Resources Committee Case" (hereinafter referred to as "Zheng Qiang Case"), “Chen Yuzhong v. Shenzhen Planning and Land Resources Committee case†(hereinafter referred to as “Chen Yuzhong Caseâ€). As of the initial filing of the IPO, the first instance of the above case was terminated and the plaintiff lost the case. From the initial declaration to the disclosure date of the announcement, the “Zheng Qiang Case†and the “Chen Yuzhong Case†were terminated at the end of the trial and the plaintiff lost the case. The “Zeng Wenying Case†was in the second instance stage. Huada Gene said that it is only a third party in the above case to participate in the lawsuit, not the plaintiff or the defendant. It is not a statutory disclosure, so the prospectus does not need to be disclosed. As a genetic testing company, Huada Gene was established in 2010 and landed on A shares on July 14 this year. In the first three quarters of this year, Huada Gene achieved revenue and net profit of 1.447 billion yuan and 312 million yuan respectively, with a growth rate of 15.07% and 21.52%. However, due to the impact of the incident, the company's share price fell successively on November 23 and 24, and fell 8.35% yesterday. The cumulative decline in the past three days was close to 26%. (Xinhua)
Orthopedic electric drill is suitable for trauma surgery, our company mainly has Multifunctional Drill Saw System, electric drill,cannulated drill, High Torgue Acetabular Reamer Drill,Craniotomy Drill and so on.
Attention
1, Medical bone drill is a short-time operation product, each use time of 10 minutes, can not be used continuously for a long time.
2, The battery is strictly prohibited high temperature, high pressure disinfection, after the operation should be taken out of the battery from the medical bone drill, into the packaging box, if not used for a long time, should not be charged and discharged once, so as to avoid plate aging.
3,The charger power cord can not receive oil, chemical solution erosion and mechanical damage.
4, Master the function of the device and the correct installation and use of the method, pay attention to maintenance, only properly maintained, in order to extend the service life, so that expensive medical equipment to use longer.
Power Drill,Orthopedic Drill,electric drill,bone drill Jiangsu Aomed Ortho Medical Technology Co.,Ltd , https://www.aomedortho.com